​ ​     SB-1121 treats cirrhosis and hepatocellular carcinoma (Hcc) in the early stages. The ingredients contained in the preparation participated in repairing and regenerating new liver parenchyma, blocking the formation of fibroblast cells, and preventing the development of liver cancer in the early stages. This preparation adds precursors to help the body strengthen antibodies and reduce the risk of inflammation, restore physiological and biochemical functions of liver cells after chronic inflammation. The product has proven to be effective in treatment, the liver regenerates satisfactorily, and the physiological and biochemical indicators return to normal.